Skip to main content

Ocimum to Offer Affy Services in Europe

NEW YORK (GenomeWeb News) – Ocimum Biosolutions said today that it will offer genomic services on Affymetrix's platform in Europe.

Ocimum said that it will provide genomic and gene expression analysis services out of its IJsselstein facility in the Netherlands.

"With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading life science companies and research centers in Europe," Ocimum CEO Anu Acharya said in a statement.

Ocimum bought the Gene Logic genomics services business in 2007 for $10 million.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.